🔗 Visit the ClinicalTrials.gov page for NCT01216826
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma. | Front Oncol | 2013 | 0.95 |
| 2 | Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy. | Paediatr Drugs | 2015 | 0.86 |
| 3 | Molecular profiling of childhood cancer: Biomarkers and novel therapies. | BBA Clin | 2014 | 0.86 |
| 4 | Targeted therapies for bone sarcomas. | Bonekey Rep | 2013 | 0.85 |
| 5 | Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma. | Int J Mol Sci | 2016 | 0.82 |
| 6 | Bone sarcomas: from biology to targeted therapies. | Sarcoma | 2012 | 0.82 |
| 7 | Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies. | Stem Cells Int | 2016 | 0.81 |
| 8 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |
| 9 | The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy. | Front Oncol | 2015 | 0.76 |